Research area · Mitochondrial research

MOTS-c research: a mitochondrial-derived peptide, in plain English

MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome. The studies in our register are in mice and in cells. It is prohibited in sport.

  • Evidence grade or review status for every compound
  • Sources listed on every page
  • US and sport status, dated
1 compoundPreclinical
Updated Nov 2026Dated on every page
MOTS-C
The research so far

What has been studied

MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene. The 2015 study that described it was done in mice with diet-induced obesity and insulin resistance. [1]

In July 2026 the FDA's compounding advisory committee voted to recommend adding MOTS-c to the 503A bulks list, against FDA staff's proposal. An advisory vote is not a rule, and no rule has followed. [2] [5]

What the research does not show

Saying what we don't know is part of the evidence.

Any effect of MOTS-c in people: one placebo-controlled phase 2 trial is registered and recruiting, and no trial giving MOTS-c to people has published results.

Anything about sport performance in people. MOTS-c is prohibited in sport.

Where it stands legally

As of November 2026. See the full tracker and the changelog.

CompoundFDA approval503A compounding (2026)WADA (2026 List)
MOTS-cNot approvedFDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yetProhibited (S4.4.1, named)

Worth knowing

Research use only

None of the compounds on this page is an FDA-approved medicine. Nothing on this page is medical advice or describes use in people.

What research use only means

No doses, ever

We publish no doses, protocols, or cycles for people, on any page.

Why we publish no doses

How we grade evidence

Grades follow study design: cell and animal studies (preclinical), small human studies, then controlled human trials, with approval tracked separately. A grade is not a promise of any effect.

Evidence grades

Questions people ask

Is MOTS-c allowed in sport?

No. WADA's Prohibited List names MOTS-c in class S4.4.1, metabolic modulators, in both the 2026 and 2027 lists. It is prohibited at all times.

Has MOTS-c been tested in people?

A placebo-controlled phase 2 trial is registered and recruiting, and no trial giving MOTS-c to people has published results. Other human studies measured the body's own MOTS-c levels, not what happens when it is given. We make no statement about effects in people.

Sources

  1. Lee C, et al. [Cell and mouse study of MOTS-c, a peptide encoded in mitochondrial DNA.] Cell Metab. 2015;21(3):443–454. PMID 25738459. doi.org/10.1016/j.cmet.2015.02.009
  2. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting page, 23–24 July 2026: agenda, voting questions and FDA briefing (no minutes posted as of 17 November 2026). www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
  3. U.S. Department of Health and Human Services. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, 28 Oct 2026. www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf
  4. World Anti-Doping Agency. Prohibited List 2026 (in force 1 January 2026) and 2027 (in force 1 January 2027). www.wada-ama.org/en/prohibited-list
  5. U.S. Department of Health and Human Services. Enforcement discretion policy, Appendix B: peptide identities and justifications, October 2026 (records the July 2026 committee outcome for each of the six peptides). www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf
  6. ClinicalTrials.gov. NCT07505745: placebo-controlled phase 2 trial of MOTS-c in adults with prediabetes and overweight or obesity (recruiting; no results). clinicaltrials.gov/study/NCT07505745

Start with the evidence

Every page sourced and dated, including what the research does not show.

Open the research library
Written by 6AM Research. Drafted with AI from published studies, trial registries, and regulator documents, plus press reports where marked. Every page lists its sources and is dated. Editorial policy · Corrections
Education only. Nothing here is medical advice or describes use in people. Research use only